Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TELO Telomir Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.19 -0.8% | $15.90 -2.5% |
| StockIQ Score | 51C- Moderate Risk: High | 41D Weak Risk: High |
| Technical | 31F | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 66B- | 50C- |
| Fair Value | 50C- | 38F |
| News | 92A+ | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Telomir Pharmaceuticals (TELO) outperforms Ascentage Pharma (AAPG) in growth and investor confidence, scoring 66 versus 50 in growth and 51 versus 41 in investor score. AAPG leads slightly in technicals (36 vs. 31) and valuation (38 vs. 50), but its fundamental score (35) is weaker than TELO’s 46. Overall, TELO shows stronger fundamentals and growth potential.
